| Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study G Cavalli, G De Luca, C Campochiaro, E Della-Torre, M Ripa, D Canetti, ... The Lancet Rheumatology 2 (6), e325-e331, 2020 | 1056 | 2020 |
| Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study C Campochiaro, E Della-Torre, G Cavalli, G De Luca, M Ripa, N Boffini, ... European journal of internal medicine 76, 43-49, 2020 | 448 | 2020 |
| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 257 | 2021 |
| GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study G De Luca, G Cavalli, C Campochiaro, E Della-Torre, P Angelillo, ... The Lancet Rheumatology 2 (8), e465-e473, 2020 | 227 | 2020 |
| Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study G Cavalli, A Larcher, A Tomelleri, C Campochiaro, E Della-Torre, ... The Lancet Rheumatology 3 (4), e253-e261, 2021 | 168 | 2021 |
| Erdheim-chester disease C Campochiaro, A Tomelleri, G Cavalli, A Berti, L Dagna European journal of internal medicine 26 (4), 223-229, 2015 | 148 | 2015 |
| Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: a monocentric survey A Tomelleri, S Sartorelli, C Campochiaro, EM Baldissera, L Dagna Annals of the rheumatic diseases 79 (9), 1252-1253, 2020 | 75 | 2020 |
| Probability-based algorithm using ultrasound and additional tests for suspected GCA in a fast-track clinic A Sebastian, A Tomelleri, A Kayani, D Prieto-Pena, C Ranasinghe, ... RMD open 6 (3), e001297, 2020 | 51 | 2020 |
| Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series C Campochiaro, N Farina, A Tomelleri, R Ferrara, C Lazzari, G De Luca, ... European Journal of Internal Medicine 93, 87-94, 2021 | 47 | 2021 |
| Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet … G Cavalli, G De Luca, C Campochiaro, E Della-Torre, M Ripa, D Canetti, ... Annals of Palliative Medicine. All rights reserved. Ann Palliat Med 10 (1 …, 2021 | 47 | 2021 |
| Treating heart inflammation with interleukin-1 blockade in a case of Erdheim–Chester disease A Tomelleri, G Cavalli, G De Luca, C Campochiaro, T D’Aliberti, ... Frontiers in Immunology 9, 1233, 2018 | 44 | 2018 |
| Spontaneous coronary-artery dissection C Campochiaro, A Tomelleri, L Dagna The New England journal of medicine 384 (11), 1077, 2021 | 43 | 2021 |
| Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data AK Hemmig, D Gozzoli, L Werlen, H Ewald, M Aschwanden, D Blockmans, ... Seminars in Arthritis and Rheumatism 55, 152017, 2022 | 41 | 2022 |
| Repurposing of biologic and targeted synthetic anti-rheumatic drugs in COVID-19 and hyper-inflammation: a comprehensive review of available and emerging evidence at the peak of … G Cavalli, N Farina, C Campochiaro, G De Luca, E Della-Torre, ... Frontiers in pharmacology 11, 598308, 2020 | 41 | 2020 |
| Respiratory impairment predicts response to IL-1 and IL-6 blockade in COVID-19 patients with severe pneumonia and hyper-inflammation E Della-Torre, M Lanzillotta, C Campochiaro, G Cavalli, G De Luca, ... Frontiers in Immunology 12, 675678, 2021 | 40 | 2021 |
| Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series A Tomelleri, C Campochiaro, G De Luca, G Cavalli, L Dagna European Journal of Internal Medicine 57, e11-e12, 2018 | 39 | 2018 |
| Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey C Campochiaro, G Trignani, A Tomelleri, S Cascinu, L Dagna Annals of the rheumatic diseases 80 (6), 816-817, 2021 | 38 | 2021 |
| Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients A Mekinian, L Biard, L Dagna, P Novikov, C Salvarani, O Espitia, ... Rheumatology 61 (4), 1376-1384, 2022 | 35 | 2022 |
| Efficacy of canakinumab as first-line biologic agent in adult-onset Still’s disease G Cavalli, A Tomelleri, G De Luca, C Campochiaro, CA Dinarello, ... Arthritis research & therapy 21, 1-2, 2019 | 35 | 2019 |
| The provisional OMERACT ultrasonography score for giant cell arteritis C Dejaco, C Ponte, S Monti, D Rozza, CA Scirè, L Terslev, GAW Bruyn, ... Annals of the rheumatic diseases 82 (4), 556-564, 2023 | 32 | 2023 |
